Test Comparison - Breast Recurrence Score®

Learn how the Breast Recurrence Score compares to traditional assessment methods, genetic tests, and other genomic assays.

Lindsay Onderick on LinkedIn: Overview │ OncoExTra™

Prognostic vs. Predictive, Oncotype DX® Test

EndoPredict gene expression profiling assay for assessing risk of

RS distribution in the N0 and N1mi/N1 patients (p = 0.804 for

Bret Nelson on LinkedIn: Explore the Report │ OncoExTra™

New Online App May Help Doctors Predict Risk of Breast Cancer

New Data Presented at SABCS ® 2021 Strengthen Value of

Precision Medicine Test for Breast Cancer Helps Guide Chemotherapy

Sarah McIsaac on LinkedIn: Test Comparison - Breast Recurrence Score®